Home

Dare Bioscience, Inc. - Common Stock (DARE)

2.9508
+0.0708 (2.46%)

Dare Bioscience Inc is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions, particularly in women's health care

The company is dedicated to addressing unmet medical needs by creating products aimed at enhancing reproductive health, contraception, and various gynecological conditions. With a portfolio of proprietary and partnered therapies, Dare Bioscience combines scientific expertise and cutting-edge technologies to deliver effective treatment options that improve the quality of life for women.

SummaryNewsPress ReleasesChartHistoricalFAQ
Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?
From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQDARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive, the market is never in short supply of birth control products.
Via TheNewswire.com · October 26, 2022
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
Organon (NYSEOGN), a global women’s healthcare company, and Daré Bioscience, Inc. NASDAQ: DARENASDAQDARE)
By Organon & Co. · Via Business Wire · March 31, 2022